Cancer Diary: When a Vaccine Is NOT about Prevention
When most of us hear the word vaccine , we think of prevention. A flu vaccine helps keep us from getting the flu. A shingles vaccine helps prevent shingles. Childhood vaccines protect us from diseases before they ever take hold. So imagine my surprise when I learned about a new melanoma vaccine that is designed for people who have already had cancer. That sounds backward at first. But it represents one of the most intriguing developments in cancer treatment in recent years. Recent clinical trial results from a personalized mRNA melanoma vaccine developed by Moderna and Merck showed a significant reduction in the risk of cancer recurrence when combined with the immunotherapy drug Keytruda. The vaccine is not intended for healthy people who want to avoid skin cancer someday. Rather, it is designed for patients who have already had melanoma removed and face the lingering question every cancer patient knows all too well: Will it come back? [statnews.com] , [time.com] , [news.cance...archu...